FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1078.933

Packageus.nlm.vsac
TypeValueSet
Id2.16.840.1.113762.1.4.1078.933
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1078.933/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.933
Version20240711
Statusactive
Date2024-07-11T01:03:01-04:00
NameT2DMMedsBenefittingASCVD
TitleT2DM meds benefitting ASCVD
Realmus
Authorityhl7
Purpose(Clinical Focus: T2DM meds benefitting ASCVD, as per ADA 2024 Standards of Care),(Data Element Scope: RxCUIs for medications containing canagliflozin, empagliflozin, dulaglutide, liraglutide, and SC semaglutide, as well as metformin and TZDs),(Inclusion Criteria: Valid RxCUis),(Exclusion Criteria: Invalidated RxCUIs)

Resources that use this resource

No resources found

Resources that this resource uses

CodeSystem
rxnormRxNorm
ValueSet
2.16.840.1.113762.1.4.1078.437TZD Thiazolidinediones
2.16.840.1.113762.1.4.1078.926Canagliflozin meds
2.16.840.1.113762.1.4.1078.927Empagliflozin meds
2.16.840.1.113762.1.4.1078.930Dulaglutide meds
2.16.840.1.113762.1.4.1078.931Liraglutide meds
2.16.840.1.113762.1.4.1078.932Semaglutide SC meds

Narrative

No narrative content found in resource

Source

Error loading source: Cannot read properties of undefined (reading 'div')